Search research articles
Contact Us
Filters
Showing results (241-250 of 263) with videos related to
Page
of 27
Sort By:
The Australian and New Zealand Journal of Psychiatry
|
December 13, 2019
Meta-analysis of randomised controlled trials with <i>N</i>-acetylcysteine in the treatment of schizophrenia
Caitlin Ob Yolland, Donal Hanratty, Erica Neill, et al.
BMC Psychiatry
|
September 16, 2016
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
Susan L Rossell, Paul S Francis, Cherrie Galletly, et al.
JAMA Network Open
|
July 28, 2022
Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia
Yue Wei, Vincent K C Yan, Wei Kang, et al.
The Australian and New Zealand Journal of Psychiatry
|
May 15, 2020
Effectiveness of embedding a specialist preventive care clinician in a community mental health service in increasing preventive care provision: A randomised controlled trial
Caitlin Mc Fehily, Kate M Bartlem, John H Wiggers, et al.
Trials
|
September 11, 2016
The Stroke and Carer Optimal Health Program (SCOHP) to enhance psychosocial health: study protocol for a randomized controlled trial
Catherine Brasier, Chantal F Ski, David R Thompson, et al.
The Lancet Regional Health. Western Pacific
|
June 23, 2025
A decade of Benzodiazepine and Z-drug use in Hong Kong: a longitudinal study
Kyung Jin Lee, Yue Wei, Shek-Ming Leung, et al.
Nutritional Neuroscience
|
May 31, 2018
Improvement of cognitive function in schizophrenia with <i>N</i>-acetylcysteine: A theoretical review
Caitlin O B Yolland, Andrea Phillipou, David J Castle, et al.
Schizophrenia Bulletin
|
July 20, 2022
N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms
Erica Neill, Susan L Rossell, Caitlin Yolland, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
October 22, 2025
A multisite study of the overlap between symptoms and cognition in schizophrenia: Une étude multicentrique sur le chevauchement entre les symptômes et les troubles cognitifs chez les personnes atteintes de schizophrénie
Rafal M Skiba, Abhijit M Chinchani, Mahesh Menon, et al.
Schizophrenia Research
|
June 26, 2024
Overlap between individual differences in cognition and symptoms of schizophrenia
Rafal M Skiba, Abhijit M Chinchani, Mahesh Menon, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 263) with videos related to
Sort By:
Page
of 27
The Australian and New Zealand Journal of Psychiatry
|
December 13, 2019
Meta-analysis of randomised controlled trials with <i>N</i>-acetylcysteine in the treatment of schizophrenia
Caitlin Ob Yolland, Donal Hanratty, Erica Neill, et al.
BMC Psychiatry
|
September 16, 2016
N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms
Susan L Rossell, Paul S Francis, Cherrie Galletly, et al.
JAMA Network Open
|
July 28, 2022
Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia
Yue Wei, Vincent K C Yan, Wei Kang, et al.
The Australian and New Zealand Journal of Psychiatry
|
May 15, 2020
Effectiveness of embedding a specialist preventive care clinician in a community mental health service in increasing preventive care provision: A randomised controlled trial
Caitlin Mc Fehily, Kate M Bartlem, John H Wiggers, et al.
Trials
|
September 11, 2016
The Stroke and Carer Optimal Health Program (SCOHP) to enhance psychosocial health: study protocol for a randomized controlled trial
Catherine Brasier, Chantal F Ski, David R Thompson, et al.
The Lancet Regional Health. Western Pacific
|
June 23, 2025
A decade of Benzodiazepine and Z-drug use in Hong Kong: a longitudinal study
Kyung Jin Lee, Yue Wei, Shek-Ming Leung, et al.
Nutritional Neuroscience
|
May 31, 2018
Improvement of cognitive function in schizophrenia with <i>N</i>-acetylcysteine: A theoretical review
Caitlin O B Yolland, Andrea Phillipou, David J Castle, et al.
Schizophrenia Bulletin
|
July 20, 2022
N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms
Erica Neill, Susan L Rossell, Caitlin Yolland, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
October 22, 2025
A multisite study of the overlap between symptoms and cognition in schizophrenia: Une étude multicentrique sur le chevauchement entre les symptômes et les troubles cognitifs chez les personnes atteintes de schizophrénie
Rafal M Skiba, Abhijit M Chinchani, Mahesh Menon, et al.
Schizophrenia Research
|
June 26, 2024
Overlap between individual differences in cognition and symptoms of schizophrenia
Rafal M Skiba, Abhijit M Chinchani, Mahesh Menon, et al.
Page
of 27